Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
6.47
+0.03 (0.47%)
Feb 3, 2026, 4:00 PM EST - Market closed
Sight Sciences Revenue
Sight Sciences had revenue of $19.91M in the quarter ending September 30, 2025, a decrease of -1.25%. This brings the company's revenue in the last twelve months to $76.05M, down -4.39% year-over-year. In the year 2024, Sight Sciences had annual revenue of $79.87M, down -1.47%.
Revenue (ttm)
$76.05M
Revenue Growth
-4.39%
P/S Ratio
4.39
Revenue / Employee
$352,093
Employees
216
Market Cap
342.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79.87M | -1.19M | -1.47% |
| Dec 31, 2023 | 81.06M | 9.73M | 13.63% |
| Dec 31, 2022 | 71.33M | 22.38M | 45.70% |
| Dec 31, 2021 | 48.96M | 21.32M | 77.12% |
| Dec 31, 2020 | 27.64M | 4.29M | 18.38% |
| Dec 31, 2019 | 23.35M | 15.82M | 210.07% |
| Dec 31, 2018 | 7.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 254.79M |
| OrthoPediatrics | 227.41M |
| RxSight | 142.09M |
| Quanterix | 130.20M |
| Owlet | 99.64M |
| Delcath Systems | 79.60M |
| Electromed | 66.22M |
| ClearPoint Neuro | 34.33M |
SGHT News
- 21 days ago - Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights - GlobeNewsWire
- 4 weeks ago - Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge - Seeking Alpha
- 3 months ago - Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewsWire
- 3 months ago - Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Sight Sciences to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 3 months ago - Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure - GlobeNewsWire